NCT06839690 Comparison of Sub-maximal Voluntary Isometric Training vs Eccentric Training in Management of De Quervain Tenosynovitis
| NCT ID | NCT06839690 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | De Quervain Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 58 participants |
| Start Date | 2024-07-18 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 58 participants in total. It began in 2024-07-18 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomised control trial and the purpose of this study is to compare the effects of Sub-maximal Voluntary Isometric Training vs Eccentric Training in Management of De Quervain Tenosynovitis
Eligibility Criteria
Inclusion Criteria: * Patients having history of pain, tenderness in thumb region from 3 weeks or more * Age 21-50 * Both genders * Individuals meeting the diagnostic criteria i.e. * A score of 3 or more out of 7 on De Quervain screening tool. * Positive Wrist hyperflexion and abduction of thumb (WHAT) test * Positive Finkelstein's / Eichhoff's test Exclusion criteria: * Diagnosed cases of Osteoarthritis of 1st CMC joint and Rheumatoid arthritis * C6 cervical radiculopathy * Any systemic inflammatory condition like septic arthritis * Carpal Tunnel Syndrome * Complex regional pain syndrome * Previous surgery impacting the first extensor compartment of the wrist * Corticosteroid injection in the radial wrist region within 3 months of enrolment into the study * If patient had undergone isometric thumb exercises or any strengthening protocol lasting greater than 2 weeks for the management of their current episode of de Quervain's syndrome
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06839690 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 50 Years, studying De Quervain Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06839690 currently recruiting?
Yes, NCT06839690 is actively recruiting participants. Contact the research team at zahranayyar727@gmail.com for enrollment information.
Where is the NCT06839690 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan.
Who is sponsoring the NCT06839690 clinical trial?
NCT06839690 is sponsored by Foundation University Islamabad. The trial plans to enroll 58 participants.